Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Igenesis is a private Chinese molecular diagnostics and IVD company focused on integrated, automated PCR-based testing platforms. The company develops sample-to-answer nucleic acid testing systems, reagent smart cartridges, instruments, and related assays for clinical, public health, forensic, and food-safety applications. Its core commercial platforms include the Galaxy and Sniffer automated nucleic acid detection systems, which are designed to automate extraction, purification, amplification, and analysis in a closed workflow. Igenesis positions itself as a molecular POCT platform company with strengths in automation, multiplex fluorescence detection, and platform compatibility. The company operates from Shanghai with additional R&D and production activities in Guangzhou and Shenzhen.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Igenesis.